TERUMO CORPORATION Financials Terumo Corporation OTC Markets
Equities
TRUMY
US88156J1051
Medical Equipment, Supplies & Distribution
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 16.17 USD | -0.68% |
|
-1.40% | -0.86% |
| 06-11 | Japan's Nikkei rises on US stocks, heavyweight chip shares | RE |
| 05-28 | Terumo Cardiovascular Announces 510(K) Clearance for the CDI Oneview?? Monitoring System | CI |
Valuation
| Fiscal Period: Maart | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Capitalization 1 | 2,505,187 | 2,796,910 | 3,021,411 | 2,816,528 | 2,661,180 | 3,897,513 | - | - |
| Enterprise Value (EV) 1 | 2,607,340 | 2,876,206 | 3,081,210 | 2,837,273 | 2,705,795 | 4,078,883 | 3,844,532 | 3,772,214 |
| P/E ratio | 31.1 x | 32.6 x | 39.1 x | 31.7 x | 30 x | 38.2 x | 30.7 x | 26.7 x |
| Yield | 0.8% | 0.75% | 0.73% | 0.91% | 1.12% | 0.81% | 0.98% | 1.09% |
| Capitalization / Revenue | 4.18 x | 4.45 x | 4.92 x | 4 x | 3.24 x | 4.4 x | 3.92 x | 3.65 x |
| EV / Revenue | 4.35 x | 4.57 x | 5.02 x | 4.03 x | 3.3 x | 4.42 x | 3.87 x | 3.53 x |
| EV / EBITDA | 17.3 x | 17.6 x | 20.2 x | 16.2 x | 14.4 x | 18.8 x | 15.7 x | 13.8 x |
| EV / FCF | 79.7 x | 103 x | 69.6 x | 45 x | 46.3 x | 60.1 x | 43.7 x | 34.3 x |
| FCF Yield | 1.26% | 0.97% | 1.44% | 2.22% | 2.16% | 1.66% | 2.29% | 2.92% |
| Price to Book | 3.6 x | 3.71 x | 3.53 x | 2.78 x | 2.4 x | 3.05 x | 2.78 x | 2.72 x |
| Nbr of stocks (in thousands) | 1,482,359 | 1,503,715 | 1,511,083 | 1,512,636 | 1,489,189 | 1,484,767 | - | - |
| Reference price 2 | 1,690 | 1,860 | 2,000 | 1,862 | 1,787 | 2,625 | 2,625 | 2,625 |
| Announcement Date | 5/9/19 | 5/18/20 | 5/12/21 | 5/12/22 | 5/15/23 | 5/14/24 | - | - |
1JPY in Million2JPY
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: Maart | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Net sales 1 | 599,481 | 628,897 | 613,842 | 703,303 | 820,209 | 921,863 | 994,409 | 1,068,806 |
| EBITDA 1 | 150,672 | 162,969 | 152,318 | 174,842 | 187,570 | 216,841 | 245,372 | 272,426 |
| EBIT 1 | 106,637 | 110,611 | 98,386 | 115,960 | 117,332 | 140,096 | 167,132 | 192,015 |
| Operating Margin | 17.79% | 17.59% | 16.03% | 16.49% | 14.31% | 15.2% | 16.81% | 17.97% |
| Earnings before Tax (EBT) 1 | 102,709 | 106,466 | 97,060 | 114,501 | 116,137 | 140,829 | 168,249 | 191,999 |
| Net income 1 | 79,470 | 85,211 | 77,268 | 88,813 | 89,325 | 106,374 | 126,848 | 145,761 |
| Net margin | 13.26% | 13.55% | 12.59% | 12.63% | 10.89% | 11.54% | 12.76% | 13.64% |
| EPS 2 | 54.35 | 56.98 | 51.16 | 58.72 | 59.50 | 71.50 | 85.40 | 98.26 |
| Free Cash Flow 1 | 32,726 | 27,969 | 44,277 | 63,013 | 58,415 | 67,904 | 87,975 | 110,000 |
| FCF margin | 5.46% | 4.45% | 7.21% | 8.96% | 7.12% | 7.37% | 8.85% | 10.29% |
| FCF Conversion (EBITDA) | 21.72% | 17.16% | 29.07% | 36.04% | 31.14% | 31.32% | 35.85% | 40.38% |
| FCF Conversion (Net income) | 41.18% | 32.82% | 57.3% | 70.95% | 65.4% | 63.84% | 69.36% | 75.47% |
| Dividend per Share 2 | 13.50 | 14.00 | 14.50 | 17.00 | 20.00 | 22.00 | 25.83 | 28.71 |
| Announcement Date | 5/9/19 | 5/18/20 | 5/12/21 | 5/12/22 | 5/15/23 | 5/14/24 | - | - |
1JPY in Million2JPY
Estimates
Income Statement Evolution (Quarterly data)
| Fiscal Period: Maart | 2020 S1 | 2021 S1 | 2022 Q2 | 2022 S1 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 S1 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 S1 | 2024 Q3 | 2024 Q4 | 2025 Q1 | 2025 Q2 | 2025 S1 | 2025 Q3 | 2025 Q4 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net sales 1 | 307,278 | 283,296 | 172,921 | 344,637 | 178,845 | 179,821 | 197,340 | 205,976 | 403,316 | 214,677 | 202,216 | 215,252 | 228,622 | 443,874 | 239,077 | 238,912 | 240,838 | 249,477 | 480,800 | 258,863 | 257,512 |
| EBITDA 1 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 58,384 | 55,177 | 62,112 | 63,149 | - | 59,607 | 60,532 |
| EBIT 1 | 59,150 | 41,824 | 29,624 | 65,857 | 28,598 | 21,505 | 30,427 | 25,550 | 55,977 | 37,537 | 23,121 | 29,644 | 36,848 | 66,492 | 39,027 | 34,577 | 39,480 | 43,143 | 78,200 | 45,151 | 41,597 |
| Operating Margin | 19.25% | 14.76% | 17.13% | 19.11% | 15.99% | 11.96% | 15.42% | 12.4% | 13.88% | 17.49% | 11.43% | 13.77% | 16.12% | 14.98% | 16.32% | 14.47% | 16.39% | 17.29% | 16.26% | 17.44% | 16.15% |
| Earnings before Tax (EBT) 1 | 58,065 | 40,659 | 29,262 | 65,282 | 27,762 | 21,457 | 29,667 | 24,957 | 54,624 | 37,476 | 24,037 | 29,804 | 36,624 | 66,428 | 39,315 | 35,086 | 40,363 | 43,825 | - | 43,762 | 43,120 |
| Net income 1 | 45,711 | 31,842 | 22,093 | 49,988 | 21,708 | 17,117 | 22,398 | 17,923 | 40,321 | 29,859 | 19,145 | 22,549 | 27,543 | 50,092 | 29,805 | 26,477 | 30,328 | 32,806 | - | 33,779 | 32,630 |
| Net margin | 14.88% | 11.24% | 12.78% | 14.5% | 12.14% | 9.52% | 11.35% | 8.7% | 10% | 13.91% | 9.47% | 10.48% | 12.05% | 11.29% | 12.47% | 11.08% | 12.59% | 13.15% | - | 13.05% | 12.67% |
| EPS 2 | 30.72 | 21.10 | 14.60 | 33.06 | 14.36 | 11.32 | 14.80 | 11.88 | 26.68 | 19.94 | 12.88 | 15.14 | 18.50 | 33.64 | 20.03 | 17.84 | 20.26 | 21.57 | - | 23.66 | 21.92 |
| Dividend per Share 2 | 7.000 | 7.000 | 8.000 | 8.000 | - | 9.000 | - | - | 9.500 | - | - | - | 11.00 | 11.00 | - | 11.00 | - | 13.00 | - | - | 13.00 |
| Announcement Date | 11/7/19 | 11/5/20 | 11/4/21 | 11/4/21 | 2/9/22 | 5/12/22 | 8/9/22 | 11/10/22 | 11/10/22 | 2/9/23 | 5/15/23 | 8/9/23 | 11/14/23 | 11/14/23 | 2/7/24 | 5/14/24 | - | - | - | - | - |
1JPY in Million2JPY
Estimates
Balance Sheet Analysis
| Fiscal Period: Maart | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Net Debt 1 | 102,153 | 79,296 | 59,799 | 20,745 | 44,615 | 26,965 | - | - |
| Net Cash position 1 | - | - | - | - | - | - | 52,981 | 125,299 |
| Leverage (Debt/EBITDA) | 0.678 x | 0.4866 x | 0.3926 x | 0.1186 x | 0.2379 x | 0.1244 x | - | - |
| Free Cash Flow 1 | 32,726 | 27,969 | 44,277 | 63,013 | 58,415 | 67,904 | 87,975 | 110,000 |
| ROE (net income / shareholders' equity) | 12.7% | 11.7% | 9.6% | 9.5% | 8.4% | 8.7% | 9.26% | 10.1% |
| ROA (Net income/ Total Assets) | 9.34% | 9.01% | 7.49% | 8.11% | 7.55% | 8.2% | 7.56% | 7.84% |
| Assets 1 | 851,025 | 945,282 | 1,031,943 | 1,095,564 | 1,182,898 | 1,296,781 | 1,677,354 | 1,858,326 |
| Book Value Per Share 2 | 470.0 | 502.0 | 567.0 | 669.0 | 746.0 | 894.0 | 945.0 | 966.0 |
| Cash Flow per Share 2 | 84.50 | 92.00 | 86.90 | 97.70 | 106.0 | 123.0 | 132.0 | 144.0 |
| Capex 1 | 60,845 | 89,510 | 77,208 | 69,230 | 75,774 | 78,426 | 92,558 | 87,472 |
| Capex / Sales | 10.15% | 14.23% | 12.58% | 9.84% | 9.24% | 8.51% | 9.31% | 8.18% |
| Announcement Date | 5/9/19 | 5/18/20 | 5/12/21 | 5/12/22 | 5/15/23 | 5/14/24 | - | - |
1JPY in Million2JPY
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Year-on-year evolution of the Yield
Change in Enterprise Value/EBITDA
Trading Rating
Investor Rating
ESG Refinitiv
Sell
Buy
Mean consensus
BUY
Number of Analysts
14
Last Close Price
2,625
JPY
Average target price
3,093
JPY
Spread / Average Target
+17.83%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| -4.72% | 182B | |
| -2.83% | 103B | |
| -5.01% | 66.94B | |
| +15.53% | 46.73B | |
| -8.53% | 45.14B | |
| +5.82% | 41.57B | |
| +17.67% | 30.48B | |
| -8.08% | 23.58B | |
| -11.17% | 22.24B |
- Stock Market
- Equities
- 4543 Stock
- TRUMY Stock
- Financials Terumo Corporation
